Norges Bank Takes Position in Humana Inc. (NYSE:HUM)

Norges Bank purchased a new position in Humana Inc. (NYSE:HUM - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 1,640,462 shares of the insurance provider's stock, valued at approximately $416,202,000. Norges Bank owned 1.36% of Humana at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Vanguard Group Inc. grew its holdings in Humana by 15.8% during the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock valued at $3,254,899,000 after buying an additional 1,751,857 shares in the last quarter. Pzena Investment Management LLC increased its holdings in shares of Humana by 44.0% in the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after purchasing an additional 1,103,132 shares during the period. Boston Partners increased its stake in Humana by 435.8% in the 4th quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock worth $279,236,000 after acquiring an additional 893,637 shares during the last quarter. Artisan Partners Limited Partnership raised its holdings in shares of Humana by 83.4% in the 4th quarter. Artisan Partners Limited Partnership now owns 673,715 shares of the insurance provider's stock valued at $170,928,000 after acquiring an additional 306,433 shares in the last quarter. Finally, Retirement Systems of Alabama raised its holdings in shares of Humana by 735.9% in the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after acquiring an additional 192,801 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Remove Ads

Wall Street Analyst Weigh In

Several research analysts recently weighed in on HUM shares. Cantor Fitzgerald restated a "neutral" rating and issued a $290.00 price objective on shares of Humana in a research report on Wednesday, February 12th. JPMorgan Chase & Co. dropped their price objective on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $283.00 price target on shares of Humana in a research note on Wednesday, February 12th. Barclays raised their price objective on Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a report on Thursday, February 13th. Finally, Truist Financial increased their price target on shares of Humana from $260.00 to $290.00 and gave the company a "hold" rating in a research report on Monday, January 6th. Eighteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $285.68.

Humana Stock Down 0.4 %

Shares of NYSE:HUM traded down $1.02 during midday trading on Wednesday, reaching $263.72. The company's stock had a trading volume of 325,053 shares, compared to its average volume of 1,750,453. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a 50 day moving average of $269.37 and a 200-day moving average of $272.67. The firm has a market capitalization of $31.83 billion, a P/E ratio of 26.50, a PEG ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date of this dividend is Friday, March 28th. Humana's payout ratio is presently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.